They can't build on the momentum because THIS IS THE PEAK for this cycle for this stock. This guy is screwing around with our capital. I'm surprised Harvey only had to have two underwriters for this secondary. I figured it would take at least six, because Harvey has lost all credibility with the street.. Just a few days ago he said the SUCCEED trial analysis would be available by the end of the year, now it's Q1 2011. I guess Harvey wanted to hedge his bets in case Rida fails.. Management at Merck will be wondering if their $70 million investment was prudent.. imho
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.